![Transparency Market Researchが調査・発行した産業分析レポートです。駆虫薬の世界市場2020-2030：薬物クラス別（ベンズイミダゾール、ピペラジン、その他）、投与経路別、用途別、標的病原菌別、流通チャンネル別 / Anthelmintic Drugs Market (Drug Class: Benzimidazoles, Piperazine, and Others; Route of Administration: Oral and Injectable; Application: Human [Parenchymal Neurocysticercosis and Gastrointestinal Infections] and Animal; Target Pathogen: Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, and Veterinary Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 / TMR2008038資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/99x123xreport-contents-07.gif.pagespeed.ic.nNxr8IHSvF.jpg) | • レポートコード：TMR2008038 • 出版社/出版日：Transparency Market Research / 2020年5月 • レポート形態：英文、PDF、ページ数はお問い合わせください。 • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは駆虫薬の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、薬物クラス別（ベンズイミダゾール、ピペラジン、その他）分析、投与経路別（経口、注射）分析、用途別（人間、動物）分析、標的病原体別（回虫、鞭虫、蟯虫、ズビニ鉤虫、その他）分析、流通チャンネル別（病院薬局、小売薬局、オンライン薬局、獣医薬局、獣医病院・診療所）分析、地域別（ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・駆虫薬の世界市場：薬物クラス別（ベンズイミダゾール、ピペラジン、その他） ・駆虫薬の世界市場：投与経路別（経口、注射） ・駆虫薬の世界市場：用途別（人間、動物） ・駆虫薬の世界市場：標的病原体別（回虫、鞭虫、蟯虫、ズビニ鉤虫、その他） ・駆虫薬の世界市場：流通チャンネル別（病院薬局、小売薬局、オンライン薬局、獣医薬局、獣医病院・診療所） ・駆虫薬の世界市場：地域別（ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Anthelmintic Drugs Market – Scope of the Report
TMR’s report on the global anthelmintic drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2020 to 2030 The report provides the overall revenue of the global anthelmintic drugs market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global anthelmintic drugs market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global anthelmintic drugs market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global anthelmintic drugs market.
The report delves into the competition landscape of the global anthelmintic drugs market. Key players operating in the global anthelmintic drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global anthelmintic drugs market report.
Key Questions Answered in Anthelmintic Drugs Market Report
What is the sales/revenue generated by the global anthelmintic drugs market across all the regions during the forecast period?
What are the key trends in the global anthelmintic drugs market?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2030 and which drug class will expand at the fastest CAGR during the forecast period?
Anthelmintic Drugs Market – Research Objectives and Research Approach
The comprehensive report on the global anthelmintic drugs market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global anthelmintic drugs market. It is followed by market introduction, market dynamics, and an overview of the global anthelmintic drugs market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the anthelmintic drugs market. The next section of the global anthelmintic drugs market report highlights the USPs, which include epidemiology of helminthic infections across globe, key industry events (product launches, approvals, acquisitions, mergers, collaborations, etc.), and impact of COVID-19 on the anthelmintic drugs market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key anthelmintic drugs manufacturers has been mapped to ascertain the size of the global anthelmintic drugs market in terms of value. The forecast presented here assesses the total revenue generated in the anthelmintic drugs market. In order to provide an accurate forecast, we initiated by sizing up the current anthelmintic drugs market with the help of the parent market.
The report analyzes the global anthelmintic drugs market in terms of drug class, route of administration, application, target pathogen, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global anthelmintic drugs market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anthelmintic Drugs Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anthelmintic Drugs Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Epidemiology of Helminthic Infections
5.2. Key Industry Events (Product Launch, Approval, Acquisition, Merger, Collaboration, etc.)
5.3. Impact of COVID-19 on Anthelmintic Drugs Market
6. Global Anthelmintic Drugs Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
6.3.1. Benzimidazoles
6.3.2. Piperazine
6.3.3. Others
6.4. Market Attractiveness Analysis, by Drug Class
7. Global Anthelmintic Drugs Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
7.3.1. Oral
7.3.2. Injectable
7.4. Market Attractiveness Analysis, by Route of Administration
8. Global Anthelmintic Drugs Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
8.3.1. Human
8.3.1.1. Parenchymal Neurocysticercosis
8.3.1.2. Gastrointestinal Infections
8.3.2. Animal
8.4. Market Attractiveness Analysis, by Application
9. Global Anthelmintic Drugs Market Analysis and Forecast, by Target Pathogen
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
9.3.1. Ascaris Lumbricoides (Roundworm)
9.3.2. Trichuris Trichiura (Whipworm
9.3.3. Enterobius Vermicularis (Pinworm)
9.3.4. Ancylostoma Duodenale (Hookworm)
9.3.5. Others
9.4. Market Attractiveness Analysis, by Target Pathogen
10. Global Anthelmintic Drugs Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Veterinary Pharmacies
10.3.5. Veterinary Hospitals & Clinics
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Anthelmintic Drugs Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Anthelmintic Drugs Market Value Forecast, by Region
11.2.1. Europe
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Anthelmintic Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. North America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
12.2.1. Benzimidazoles
12.2.2. Piperazine
12.2.3. Others
12.3. North America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
12.3.1. Oral
12.3.2. Injectable
12.4. North America Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
12.4.1. Human
12.4.1.1. Parenchymal Neurocysticercosis
12.4.1.2. Gastrointestinal Infections
12.4.2. Animal
12.5. North America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
12.5.1. Ascaris Lumbricoides (Roundworm)
12.5.2. Trichuris Trichiura (Whipworm
12.5.3. Enterobius Vermicularis (Pinworm)
12.5.4. Ancylostoma Duodenale (Hookworm)
12.5.5. Others
12.6. North America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.6.4. Veterinary Pharmacies
12.6.5. Veterinary Hospitals & Clinics
12.7. North America Anthelmintic Drugs Market Value Forecast, by Country, 2018–2030
12.7.1. U.S.
12.7.2. Canada
12.8. North America Anthelmintic Drugs Market Attractiveness Analysis
12.8.1. By Drug Class
12.8.2. By Route of Administration
12.8.3. By Application
12.8.4. By Target Pathogen
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Anthelmintic Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Europe Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
13.2.1. Benzimidazoles
13.2.2. Piperazine
13.2.3. Others
13.3. Europe Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
13.3.1. Oral
13.3.2. Injectable
13.4. Europe Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
13.4.1. Human
13.4.1.1. Parenchymal Neurocysticercosis
13.4.1.2. Gastrointestinal Infections
13.4.2. Animal
13.5. Europe Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
13.5.1. Ascaris Lumbricoides (Roundworm)
13.5.2. Trichuris Trichiura (Whipworm
13.5.3. Enterobius Vermicularis (Pinworm)
13.5.4. Ancylostoma Duodenale (Hookworm)
13.5.5. Others
13.6. Europe Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.6.4. Veterinary Pharmacies
13.6.5. Veterinary Hospitals & Clinics
13.7. Europe Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Europe Anthelmintic Drugs Market Attractiveness Analysis
13.8.1. By Drug Class
13.8.2. By Route of Administration
13.8.3. By Application
13.8.4. By Target Pathogen
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Anthelmintic Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
14.2.1. Benzimidazoles
14.2.2. Piperazine
14.2.3. Others
14.3. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
14.3.1. Oral
14.3.2. Injectable
14.4. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
14.4.1. Human
14.4.1.1. Parenchymal Neurocysticercosis
14.4.1.2. Gastrointestinal Infections
14.4.2. Animal
14.5. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
14.5.1. Ascaris Lumbricoides (Roundworm)
14.5.2. Trichuris Trichiura (Whipworm
14.5.3. Enterobius Vermicularis (Pinworm)
14.5.4. Ancylostoma Duodenale (Hookworm)
14.5.5. Others
14.6. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Pharmacies
14.6.4. Veterinary Pharmacies
14.6.5. Veterinary Hospitals & Clinics
14.7. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis
14.8.1. By Drug Class
14.8.2. By Route of Administration
14.8.3. By Application
14.8.4. By Target Pathogen
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Anthelmintic Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Latin America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
15.2.1. Benzimidazoles
15.2.2. Piperazine
15.2.3. Others
15.3. Latin America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
15.3.1. Oral
15.3.2. Injectable
15.4. Latin America Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
15.4.1. Human
15.4.1.1. Parenchymal Neurocysticercosis
15.4.1.2. Gastrointestinal Infections
15.4.2. Animal
15.5. Latin America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
15.5.1. Ascaris Lumbricoides (Roundworm)
15.5.2. Trichuris Trichiura (Whipworm
15.5.3. Enterobius Vermicularis (Pinworm)
15.5.4. Ancylostoma Duodenale (Hookworm)
15.5.5. Others
15.6. Latin America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Pharmacies
15.6.4. Veterinary Pharmacies
15.6.5. Veterinary Hospitals & Clinics
15.7. Latin America Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Latin America Anthelmintic Drugs Market Attractiveness Analysis
15.8.1. By Drug Class
15.8.2. By Route of Administration
15.8.3. By Application
15.8.4. By Target Pathogen
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Anthelmintic Drugs Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
16.2.1. Benzimidazoles
16.2.2. Piperazine
16.2.3. Others
16.3. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
16.3.1. Oral
16.3.2. Injectable
16.4. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
16.4.1. Human
16.4.1.1. Parenchymal Neurocysticercosis
16.4.1.2. Gastrointestinal Infections
16.4.2. Animal
16.5. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
16.5.1. Ascaris Lumbricoides (Roundworm)
16.5.2. Trichuris Trichiura (Whipworm
16.5.3. Enterobius Vermicularis (Pinworm)
16.5.4. Ancylostoma Duodenale (Hookworm)
16.5.5. Others
16.6. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
16.6.1. Hospital Pharmacies
16.6.2. Retail Pharmacies
16.6.3. Online Pharmacies
16.6.4. Veterinary Pharmacies
16.6.5. Veterinary Hospitals & Clinics
16.7. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis
16.8.1. By Drug Class
16.8.2. By Route of Administration
16.8.3. By Application
16.8.4. By Target Pathogen
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competitive Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of companies)
17.2. Company Profiles
17.2.1. Novartis AG
17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.1.2. Financial Overview
17.2.1.3. Product Portfolio
17.2.1.4. Strategic Overview
17.2.1.5. SWOT Analysis
17.2.2. Zoetis, Inc.
17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.2.2. Financial Overview
17.2.2.3. Product Portfolio
17.2.2.4. Strategic Overview
17.2.2.5. SWOT Analysis
17.2.3. Amneal Pharmaceuticals Inc.
17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.3.2. Financial Overview
17.2.3.3. Product Portfolio
17.2.3.4. Strategic Overview
17.2.3.5. SWOT Analysis
17.2.4. Cipla Inc.
17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.4.2. Financial Overview
17.2.4.3. Product Portfolio
17.2.4.4. Strategic Overview
17.2.4.5. SWOT Analysis
17.2.5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.5.2. Financial Overview
17.2.5.3. Product Portfolio
17.2.5.4. Strategic Overview
17.2.5.5. SWOT Analysis
17.2.6. Sun Pharmaceutical Industries Ltd
17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.6.2. Financial Overview
17.2.6.3. Product Portfolio
17.2.6.4. Strategic Overview
17.2.6.5. SWOT Analysis
17.2.7. GlaxoSmithKline plc
17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.7.2. Financial Overview
17.2.7.3. Product Portfolio
17.2.7.4. Strategic Overview
17.2.7.5. SWOT Analysis
17.2.8. Bayer AG
17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.8.2. Financial Overview
17.2.8.3. Product Portfolio
17.2.8.4. Strategic Overview
17.2.8.5. SWOT Analysis
17.2.9. Merck & Co. Inc. (Intervet Inc.)
17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.9.2. Financial Overview
17.2.9.3. Product Portfolio
17.2.9.4. Strategic Overview
17.2.9.5. SWOT Analysis
17.2.10. Boehringer Ingelheim International GmbH
17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.10.2. Financial Overview
17.2.10.3. Product Portfolio
17.2.10.4. Strategic Overview
17.2.10.5. SWOT Analysis
List of TablesTable 01: Europe Anthelmintic Drugs Market - Prevalence
Table 02: Europe Anthelmintic Drugs Market - Prevalence
Table 03: Global Anthelmintic Drugs Market Forecast, by Drug Class
Table 04: Global Anthelmintic Drugs Market Forecast, by Route of Administration
Table 05: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2020–2030
Table 06: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2020–2030
Table 07: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030
Table 08: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 09: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Region, 2018-2030
Table 10: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country, 2018?2030
Table 11: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030
Table 12: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018?2030
Table 13: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table 14: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030
Table 15: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030
Table 16: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030
Table 17: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
Table 18: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030
Table 19: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018?2030
Table 20: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table 21: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030
Table 22: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030
Table 23: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030
Table 24: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 25: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 26: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018–2030
Table 27: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 28: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human Application, 2018–2030
Table 29: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030
Table 30: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 31: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 32: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 33: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 34: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 35: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018–2030
Table 36: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030
Table 37: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 38: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 39: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 40: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 41: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 42: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018–2030
Table 43: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030
Table 44: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030